BREAKING
Home » Posts Tagged "RELIEF THERAPEUTICS"

Phase 2/3 clinical trial for critically ill COVID-19 patients continues to enroll patients as cases surge across the country

By

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holdings AG today announced that the independent Data Monitoring Committee has reviewed the findings in the first 30 patients treated in Fast Track...

Fast Track Designation of RLF-100 for the treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome associated with COVID-19

By

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holding AG today announced that the U.S. Food and Drug Administration (FDA) awarded Fast Track Designation to NeuroRx for the investigation of RLF-100...